Sara Tartof to Infant
This is a "connection" page, showing publications Sara Tartof has written about Infant.
Connection Strength
0.833
-
Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection. JAMA Netw Open. 2022 08 01; 5(8):e2225657.
Score: 0.158
-
Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
Score: 0.102
-
Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014 Nov 12; 32(48):6408-14.
Score: 0.092
-
Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc. 2014 Sep; 89(9):1229-38.
Score: 0.091
-
Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 May 07; 32(22):2574-81.
Score: 0.089
-
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One. 2013; 8(5):e63605.
Score: 0.084
-
Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013 Apr; 131(4):e1047-52.
Score: 0.083
-
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy. Vaccine. 2022 Jul 30; 40(32):4503-4512.
Score: 0.039
-
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
Score: 0.039
-
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. 2020 01 10; 38(2):228-234.
Score: 0.033
-
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
Score: 0.024